유백피 추출물을 포함하는 혈관 이완용 조성물
    4.
    发明公开
    유백피 추출물을 포함하는 혈관 이완용 조성물 有权
    包含ULMUS MACROCARPA提取物的挥发性效应的组合物

    公开(公告)号:KR1020090064823A

    公开(公告)日:2009-06-22

    申请号:KR1020070132164

    申请日:2007-12-17

    Abstract: A composition for relaxing blood vessel which contains an Ulmus macrocarpa extract prevent and treat various cardiovascular diseases by inducing the relaxation of vascular smooth muscle. A pharmaceutical composition for relaxing blood vessel contains an Ulmus macrocarpa extract as an active ingredient. The composition is effective in preventing and treating hypertension, coronary artery disease, cerebrovascular disease, peripheral vascular disease, main artery disease, kidney dysfunction, cardiac insufficiency or vision disorder An organic solvent for extracting the Ulmus macrocarpa is selected from ethanol, ethanol solution, methanol, methanol solution, butanol, dichloromethane, ethyl acetate, hexane and their mixture. A health food having the effect of blood vessel relaxation contains Ulmus macrocarpa extract.

    Abstract translation: 用于放松血管的组合物含有榆木提取物通过诱导血管平滑肌的松弛来预防和治疗各种心血管疾病。 用于放松血管的药物组合物含有榆木大pa提取物作为活性成分。 该组合物有效预防和治疗高血压,冠状动脉疾病,脑血管疾病,外周血管疾病,主动脉疾病,肾功能不全,心功能不全或视力障碍。用于提取榆树的有机溶剂选自乙醇,乙醇溶液,甲醇 ,甲醇溶液,丁醇,二氯甲烷,乙酸乙酯,己烷及其混合物。 具有血管松弛作用的保健食品包含榆树提取物。

    삼백초 추출물 또는 이로부터 분리된 활성 화합물을포함하는 골다공증 예방 또는 치료용 조성물
    5.
    发明授权
    삼백초 추출물 또는 이로부터 분리된 활성 화합물을포함하는 골다공증 예방 또는 치료용 조성물 有权
    用于预防或治疗包含SAURURUS CHINENSIS或活性化合物提取物的OSTEOPOSOSIS的组合物,其分离

    公开(公告)号:KR100833654B1

    公开(公告)日:2008-05-29

    申请号:KR1020070013661

    申请日:2007-02-09

    CPC classification number: A61K36/78

    Abstract: A composition comprising the extract of Saururus chinensis or active compounds isolated therefrom is provided to inhibit growth of osteoclast, so that the composition is useful for preventing or treating osteoporosis. A composition for preventing or treating osteoporosis comprises 0.01-30 wt.% of the extract of Saururus chinensis, which is prepared by extracting Saururus chinensis with C1-4 alcohol and its solution, dichloromethane, ethylacetate or a mixture thereof, or active compounds isolated from the Saururus chinensis extract including (-)-saucerneol represented by the formula(1) and sauristolactam represented by the formula(2), and is a pharmaceutical or health food composition having a formulation of beverage.

    Abstract translation: 提供了包含中华黄牛提取物或从其分离的活性化合物的组合物以抑制破骨细胞的生长,使得该组合物可用于预防或治疗骨质疏松症。 用于预防或治疗骨质疏松症的组合物包括通过用C 1-4醇提取中华黄芪和其溶液,二氯甲烷,乙酸乙酯或其混合物或从其中分离的活性化合物制备的中华黄瓜提取物的0.01-30重量% 含有由式(1)表示的( - ) - 三氯蔗糖和由式(2)表示的沙拉耳内酰胺,是具有饮料配方的药物或保健食品组合物。

    BACE-1의 활성을 저해하는 파고지 종자 추출물 또는이로부터 분리된 활성물질을 포함하는 퇴행성 뇌질환의예방 또는 치료용 조성물
    6.
    发明授权
    BACE-1의 활성을 저해하는 파고지 종자 추출물 또는이로부터 분리된 활성물질을 포함하는 퇴행성 뇌질환의예방 또는 치료용 조성물 有权
    用于预防或治疗包含来自一种PSORALEA CORYLIFOLIA的一种提取物的神经变性疾病的组合物抑制BACE-1或其活性成分的活性

    公开(公告)号:KR100833652B1

    公开(公告)日:2008-05-29

    申请号:KR1020060136696

    申请日:2006-12-28

    Abstract: A composition comprising the extract of Psoralea corylifolia seed or effective compounds contained therein is provided to inhibit the activity of BACE-1(beta-site APP(amyloid precursor protein)-cleaving enzyme 1) mediating the formation of beta-amyloid as a main causing material of dementia, so that the composition is useful for preventing or treating neurodegenerative disease. A composition for preventing or treating neurodegenerative disease comprises the extract of Psoralea corylifolia seed, which is prepared by extracting Psoralea corylifolia seeds with C1-4 alcohol or its solution, dichloromethane, ethylacetate or a mixture thereof, or a compound selected from 7-hydroxy-3-(4-methyl-4-(4-methylpentene-3-yl)-4H-chromen-6-yl)-4H-chromen-4-one represented by the formula(1), bakuchiol, bavachromene, isobavachromene, bavachalcone, isobavachalcone, bavachinin, 7,8-dihydro-8-(4-hydrophenyl)-2,2-dimethyl-2H,6H-[1,2-b:5,4-b']dipyran-6-one isolated from the extract of Psoralea corylifolia seed.

    Abstract translation: 提供包含补骨脂素提取物或其中含有的有效化合物的组合物以抑制BACE-1(β-位点APP(淀粉样蛋白前体蛋白)切割酶1)的活性,其介导β-淀粉样蛋白的形成作为主要原因 因此该组合物可用于预防或治疗神经退行性疾病。 用于预防或治疗神经退行性疾病的组合物包括通过用C 1-4醇或其溶液,二氯甲烷,乙酸乙酯或其混合物或选自7-羟基-2-甲基苯酚的化合物提取茄科植物提取物的方法制备的补骨脂素提取物, 由式(1)表示的3-(4-甲基-4-(4-甲基戊烯-3-基)-4H-色烯-6-基)-4H-色烯-4-酮,苯甲酸,巴伐溴苯,异葎草酮,巴伐昔酮 ,异哈查酮,巴伐他丁,7,8-二氢-8-(4-氢苯基)-2,2-二甲基-2H,6H- [1,2-b:5,4-b']二吡喃-6-酮 茯苓提取物。

    폴리페놀계 화합물을 함유하는 퇴행성 뇌질환의 예방 또는치료용 조성물
    7.
    发明公开
    폴리페놀계 화합물을 함유하는 퇴행성 뇌질환의 예방 또는치료용 조성물 无效
    包含用于预防或治疗神经变性疾病的聚苯醚化合物的组合物

    公开(公告)号:KR1020090078939A

    公开(公告)日:2009-07-21

    申请号:KR1020080004805

    申请日:2008-01-16

    Abstract: A composition for preventing and treating neutodegenerative disease, which contains a polyphenol compound as an active ingredient is provided to have the effects of beta-amyloid coagulation inhibition, caspase-3 activity suppression and acetylcholinesterase activation suppression. A composition for preventing and treating neurodegenerative diseases comprises salvianolic acid, bakuchiol, epsilon-viniferin, rhapontigenin, piceatannol, luteolin, myricetin, or their mixture as an active ingredient. The neurodegenerative diseases are Alzheimer's disease, Pick's disease, Creutzfeldt-jakob, Parkinson's disease, Lou Gehrig's Disease, or Huntington's disease. The composition suppresses BACE-1[beta-site APP(amyloid precursor protein)-cleaving enzyme 1], caspase or acetylcholine esterase. The composition further comprises medicinal herb. The medicinal herb is Salviae Miltiorrhizae Radix, Psoraleae Semen, Vitidis Fructus, Rhei Rhizoma, Digitalis Folium, Schizonepeta Herba, Taraxaci Herba, Humuli Herba, Lonicerae Folium or their mixture.

    Abstract translation: 提供含有多酚化合物作为活性成分的用于预防和治疗神经变性疾病的组合物,以具有β-淀粉样蛋白凝结抑制,半胱天冬酶-3活性抑制和乙酰胆碱酯酶活化抑制的作用。 用于预防和治疗神经变性疾病的组合物包括salvianolic acid,bakuchiol,ε-viniferin,rhapontigenin,piceatannol,木犀草素,杨梅宁或其混合物作为活性成分。 神经变性疾病是阿尔茨海默氏病,皮克病,克雅氏综合征,帕金森氏病,卢格里希氏病或亨廷顿舞蹈病。 该组合物抑制BACE-1β-位点APP(淀粉样蛋白前体蛋白)切割酶1],半胱天冬酶或乙酰胆碱酯酶。 该组合物还包含药草。 药用草药是丹参,枸杞子,枸杞子,枸杞子,洋地黄属,荆芥草,竹aci草,虎嘴草,金银花或其混合物。

    포도 줄기 껍질로부터 분리된 레스베라트롤 유도체 화합물을 포함하는 항암제 조성물
    8.
    发明公开
    포도 줄기 껍질로부터 분리된 레스베라트롤 유도체 화합물을 포함하는 항암제 조성물 审中-实审
    用于治疗包含来自葡萄膜干燥分离的抑制剂衍生物的癌症的药物组合物

    公开(公告)号:KR1020120116115A

    公开(公告)日:2012-10-22

    申请号:KR1020110033674

    申请日:2011-04-12

    Abstract: PURPOSE: An anticancer drug composition including resveratrol derivative compound separated from grape stem shell is provided to prevent and treat all kinds of cancers including lung cancer, ovarian cancer, melanoma, central nervous system tumor, colon carcinoma, and leukemia. CONSTITUTION: An anticancer drug composition includes vitisinol C, vitisinol E, cis-vitisin A, vitisin B, vitisin C, a pharmaceutically acceptable salt and isomer or a mixture thererof, and grape stem shell extract including thereof as an active ingredient. The grape stem shell extract is obtained by extracting methanol, methanol aqueous solution, ethanol, ethanol aqueous solution, butanol, dichloromethane, ethyl acetate or a mixture thereof. The cancer is lung cancer, ovarian cancer, melanoma or colon carcinoma. A health enhancement food having cancer cell growth inhibition efficacy contains vitisinol C, vitisinol E, cis-viticin A, viticin B, viticin C, pharmaceutically acceptable salt, isomer or a mixture thereof, and grapes stem shell extract including the same. The food is in beverage form. The grape stem shell extract is obtained by the following steps: extracting the grape stem shell by methanol and suspending the obtained extract in distilled water; partitioning thereof by dichloromethane; and extracting the obtained water layer by ethyl acetate.

    Abstract translation: 目的:提供包括从葡萄茎壳分离的白藜芦醇衍生物化合物的抗癌药物组合物,用于预防和治疗各种癌症,包括肺癌,卵巢癌,黑素瘤,中枢神经系统肿瘤,结肠癌和白血病。 构成:抗癌药物组合物包括维生素C,维生素E,顺式维生素A,维生素B,维生素C,其药学上可接受的盐和异构体或其混合物,以及包含它们的葡萄茎壳提取物作为活性成分。 葡萄茎壳提取物是通过提取甲醇,甲醇水溶液,乙醇,乙醇水溶液,丁醇,二氯甲烷,乙酸乙酯或其混合物得到的。 癌症是肺癌,卵巢癌,黑素瘤或结肠癌。 具有癌细胞生长抑制作用的健康增强食品包含维生素C,维生素E,顺式维生素A,维生素B,维生素C,其药学上可接受的盐,异构体或其混合物,以及包含其的葡萄茎壳提取物。 食物是饮料形式。 通过以下步骤获得葡萄茎壳提取物:用甲醇萃取葡萄茎壳,将得到的提取物悬浮于蒸馏水中; 用二氯甲烷分配; 并用乙酸乙酯萃取得到的水层。

    도라지 또는 도라지 추출물로부터의 순도 및 유효 사포닌 함량이 증가된 조사포닌 조성물의 제조방법
    9.
    发明公开
    도라지 또는 도라지 추출물로부터의 순도 및 유효 사포닌 함량이 증가된 조사포닌 조성물의 제조방법 无效
    用于制备柚苷组合物的方法提高纯度和有效的曙光内含物从平板大戟或其提取物

    公开(公告)号:KR1020110012431A

    公开(公告)日:2011-02-09

    申请号:KR1020090070151

    申请日:2009-07-30

    Abstract: PURPOSE: A method for preparing crude saponin composition with improved purity and enhanced effective saponin content is provided. CONSTITUTION: A method for preparing crude saponin composition with improved purity and enhanced effective saponin content from platycodon grandiflorum or extract thereof comprises: a step of extracting platycodon grandiflorum using distilled water, low alcohol of C1-C3, ethyl acetate, hexane, dichloromethane or mixture solvent thereof; a step of dissolving the extract in a distilled water and adsorbing saponin ingredient; a step of eluting the adsorbed saponin with ethanol or methanol solution to obtain saponin; and a step of purifying saponin using an organic solvent.

    Abstract translation: 目的:提供一种改善纯度和提高有效皂苷含量的粗皂苷组合物的方法。 制备方法:提供纯化度高,皂甙含量提高的粗皂苷组合物的方法包括:使用蒸馏水,C1-C3,乙酸乙酯,己烷,二氯甲烷或混合物的低级醇提取桔梗的步骤 溶剂; 将提取物溶解在蒸馏水中并吸附皂苷成分的步骤; 用乙醇或甲醇溶液洗脱吸附的皂角苷以获得皂苷的步骤; 和使用有机溶剂提纯皂苷的步骤。

    MCH-1 수용체 길항활성을 가지는 상엽 추출물, 이의 분획물 또는 이로부터 분리된 화합물을 유효성분으로 함유하는 식욕 억제용 또는 정신질환의 예방 및 치료용 약학적 조성물
    10.
    发明授权
    MCH-1 수용체 길항활성을 가지는 상엽 추출물, 이의 분획물 또는 이로부터 분리된 화합물을 유효성분으로 함유하는 식욕 억제용 또는 정신질환의 예방 및 치료용 약학적 조성물 失效
    含有作为活性成分的MCH-1受体拮抗作用的含有抑制或预防和治疗心理疾病的药物组合物,其含有MORI FOLIUM的提取物,其分离物或其分离的化合物,具有MCH-1受体拮抗作用

    公开(公告)号:KR100953870B1

    公开(公告)日:2010-04-20

    申请号:KR1020090075413

    申请日:2009-08-14

    Abstract: 본 발명은 멜라닌 농축 호르몬(Melanin Concentrating Hormone, MCH) 수용체에 대한 길항활성을 가지는 상엽 추출물, 이의 분획물 또는 퍼퓨린-7 디메틸 에틸에스테르, 하이드록시-페오포르바이드 A 에틸에스테르, 페오포르바이드 A 에틸에스테르, 디데하이드로-로도클로린 에틸메틸에스테르, 하이드록시 페오포르바이드 A 메틸에스테르 또는 페오포르바이드 A 메틸에스테르 또는 이들의 혼합물을 유효성분으로 함유하는 식욕 억제용 또는 중추신경 장애의 예방 및 치료용 약학적 조성물에 관한 것으로서, 본 발명에 따른 약학적 조성물은 멜라닌 농축호르몬 수용체 아형-1(Melanin Concentration Hormone receptor subtype-1, MCH-1)에 대해 강한 길항 작용을 나타내어 식욕억제효과, 불안(anxiety)이나 우울(depression)등 감정 조절 효과 등을 가지므로, 식욕 억제용 조성물로서 유용하게 사용될 수 있고, 우울증, 불안증과 같은 정신 질환(psychiatric disorder)의 예방 및 치료에 유용하게 사용될 수 있다.
    상엽 추출물, MCH, MCH-1 수용체, 식욕 억제, 우울, 불안, 퍼퓨린-7 디메틸 에틸에스테르, 페오포르바이드 A 에틸에스테르, 하이드록시-페오포르바이드 A 에틸에스테르

Patent Agency Ranking